| Organism | Antimicrobial agent | S ≥ | R < | ATU |
|---|---|---|---|---|
| P. aeruginosa | Meropenem (indications other than meningitis) | 20 | 14 | – |
| Meropenem (meningitis) | 20 | 20 | ||
| Pseudomonasspp. | Levofloxacin | 50 | 18 | |
| S. epidermidisand S.lugdunensis | Cefoxitin (screen only) | 27 | 27 | 27 |
| S. aureus | Amikacin | (15) | (15) | |
| Coagulase-negative staphylococci | Amikacin | (15) | (15) | |
| Tobramycin | (20) | (20) | ||
| Staphylococcus spp. | Erythromycin (screen only) | 21 | 21 | |
| Clindamycin | 22 | 22 | ||
| Tetracycline (screen only) | 22 | 22 | ||
| Tedizolid | 20 | 20 | 19 | |
| Rimfampicin | 26 | 26 | ||
| Streptococcus group A,B,C, and G | Tetracycline (screen only) | 23 | 23 | |
| Rimfampicin | 21 | 21 | ||
| S. pneumoniae | Ampicillin (indications other than meningitis) | 22 | 19 | |
| Tetracycline (screen only) | 25 | 25 | ||
| Rimfampicin | 22 | 22 | ||
| H. influenzae | Cefotaxime (meningitis) | 27 | 27 | 25-27 |
| Cefotriaxone (meningitis) | 32 | 32 | 31-33 | |
| Tetracyline | 25 | 25 | ||
| M. catarrhalis | Tetracyline | 26 | 26 | |
| B. pseudomallei | Tetracycline (screen only) | 23 | 23 | – |
| Organism | Antimicrobial agent | S ≤ | R > |
|---|---|---|---|
| Pseudomonas spp. | Levofloxacin | 0.001 | 2 |
| S. aureus | Delafloxacin (community-acquired pneumonia) | 0.016 | 0.016 |
| Delafloxacin (skin and skin structure infections) | 0.25 | 0.25 | |
| Amikacin | (16) | (16) | |
| Gentamicin | (2) | (2) | |
| Tobramycin | (2) | (2) | |
| Coagulase-negative staphylococci | Amikacin | (16) | (16) |
| Gentamicin | (2) | (2) | |
| Tobramycin | (2) | (2) | |
| Staphylococcus spp. | Azithromycin | 2 | 2 |
| Erythromycin (screen only) | 1 | 1 | |
| Clindamycin | 0.25 | 0.25 | |
| Tetracycline (screen only) | 1 | 1 | |
| Rimfampicin | 0.06 | 0.06 | |
| Streptococcus group A,B,C, and G | Tetracycline (screen only) | 1 | 1 |
| Rimfampicin | 0.06 | 0.06 | |
| S. pneumoniae | Ampicillin (indications other than meningitis) | 0.5 | 1 |
| Tetracycline (screen only) | 1 | 1 | |
| Rimfampicin | 0.125 | 0.125 | |
| H. influenzae | Cefotaxime (meningitis) | 0.125 | 0.125 |
| Cefotriaxone (meningitis) | 0.125 | 0.125 | |
| Tetracyline | 2 | 2 | |
| M. catarrhalis | Tetracyline | 2 | 2 |
The revised part is indicated in bold type. Breakpoints in brackets are based on epidemiological cut-off. Abbreviations: EUCAST, European Committee on Antimicrobial Susceptibility Testing; ATU, area of technical uncertainly; S, susceptible; R, resistance; MIC, minimal inhibitory concentration.